US FDA Would See Cash Windfall In COVID-19 Relief Bill
Executive Summary
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
You may also be interested in...
Biden Leaves US FDA Largely Out Of Budget Outline
FDA is only mentioned once in the document, and its temporary leadership may not be the reason why.
Advanced Manufacturing May Require US FDA To Think Differently About Guidance
National Academies report argues that technologies cannot only be evaluated in the context of specific products, and FDA guidance should become both ‘more fluid and targeted.’
US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.